Search
for
Sort by
Research 30 of 1000+
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Safety Profile for Microneedling: A Systematic Review
- Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
- Diagnostic Comparison: SH‑1 Molecule vs PP405 — Safety Profiles in Hair Science
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation
- Safety profile of topical spray minoxidil: An observational study
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- Mesotherapy: Safety profile and management of complications
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Unknown safety profile of ingredients in hair supplements: A call to action for improved patient safety
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review.
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system
- Clinical Outcome and Safety Profile of Patients Underwent Hair Transplantation Surgery by Follicular Unit Extraction
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Understanding the safety profile of topical minoxidil: a retrospective review
- Effectiveness and Safety Profile of Cisplatin Versus Nab-Paclitaxel Concomitant Chemoradiotherapy in Postoperative Early-Stage Cancer of Cervix
- Tolerance and Safety Profile of Sublingual Minoxidil in the Treatment of Androgenic Alopecia
- Tolerance and safety profile of sublingual minoxidil in the treatment of androgenic alopecia
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Assessment of Efficacy and Safety Profile of Platelet Rich Plasma (PRP) Therapy with Derma Roller in the Treatment of Female Pattern Hair Loss
- Increasing the Safety Profile of Follicular Unit Extraction by Eliminating the Use of Bupivacaine and Nerve Block: Experience from a Tertiary Care Center of North India.